Some 17 million people across the US, UK, Germany, and France are living with the most aggressive form of fatty liver disease ...

More than 15 million people across the US, UK, Germany and France are unknowingly living with metabolic ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

A new study reveals that dapagliflozin, a common diabetes medication, could significantly improve conditions like metabolic ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

About 89bio 89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment ...

Modern unhealthy lifestyles and dietary habits have led to a yearly increase in the incidence of metabolism-related liver ...

The mammalian liver has an extraordinary regenerative capacity, capable of fully restoring its mass and function after injury ...

First Installation at Hemas Hospital Wattala DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced ...